Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells.

Gilardini Montani MS, Cecere N, Granato M, Romeo MA, Falcinelli L, Ciciarelli U, D'Orazi G, Faggioni A, Cirone M.

Cancers (Basel). 2019 May 22;11(5). pii: E703. doi: 10.3390/cancers11050703.

2.

Could autophagy dysregulation link neurotropic viruses to Alzheimer's disease?

Romeo MA, Faggioni A, Cirone M.

Neural Regen Res. 2019 Sep;14(9):1503-1506. doi: 10.4103/1673-5374.253508. Review.

3.

STAT3 phosphorylation affects p53/p21 axis and KSHV lytic cycle activation.

Santarelli R, Carillo V, Romeo MA, Gaeta A, Nazzari C, Gonnella R, Granato M, D'Orazi G, Faggioni A, Cirone M.

Virology. 2019 Feb;528:137-143. doi: 10.1016/j.virol.2018.12.015. Epub 2019 Jan 5.

PMID:
30616203
4.

Impact of HHV-6A and HHV-6B lytic infection on autophagy and endoplasmic reticulum stress.

Romeo MA, Masuelli L, Gaeta A, Nazzari C, Granato M, Gilardini Montani MS, Faggioni A, Cirone M.

J Gen Virol. 2019 Jan;100(1):89-98. doi: 10.1099/jgv.0.001176. Epub 2018 Nov 14.

PMID:
30427305
5.

Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response.

Romeo MAL, Martinelli V, Dalla Costa G, Colombo B, De Feo D, Esposito F, Ferrè L, Guaschino C, Guerrieri S, Liberatore G, Martinelli Boneschi F, Merlini A, Messina M, Messina R, Nuara A, Preziosa P, Radaelli M, Rocca MA, Rodegher M, Sangalli F, Strambo D, Moiola L, Comi G.

Acta Neurol Scand. 2018 Nov;138(5):447-453. doi: 10.1111/ane.12999. Epub 2018 Jul 22.

PMID:
30033621
6.

Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy.

Granato M, Romeo MA, Tiano MS, Santarelli R, Gonnella R, Gilardini Montani MS, Faggioni A, Cirone M.

Sci Rep. 2017 Oct 12;7(1):13052. doi: 10.1038/s41598-017-13533-7.

7.

Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation.

Granato M, Gilardini Montani MS, Romeo MA, Santarelli R, Gonnella R, D'Orazi G, Faggioni A, Cirone M.

Cell Signal. 2017 Dec;40:239-247. doi: 10.1016/j.cellsig.2017.09.020. Epub 2017 Sep 28.

PMID:
28964970
8.

Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study.

Zecca C, Merlini A, Disanto G, Rodegher M, Panicari L, Romeo MAL, Candrian U, Messina MJ, Pravatà E, Moiola L, Stefanin C, Ghezzi A, Perrone P, Patti F, Comi G, Gobbi C, Martinelli V.

Mult Scler. 2018 Feb;24(2):167-174. doi: 10.1177/1352458517694089. Epub 2017 Feb 1.

PMID:
28273776
9.

Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt's lymphoma.

Granato M, Rizzello C, Romeo MA, Yadav S, Santarelli R, D'Orazi G, Faggioni A, Cirone M.

Int J Biochem Cell Biol. 2016 Oct;79:393-400. doi: 10.1016/j.biocel.2016.09.006. Epub 2016 Sep 9.

PMID:
27620077
10.

Erythrocytapheresis is a valid and safe therapeutic option in dysmetabolic iron overload syndrome.

Vetro C, Rosso R, Palmucci S, Russello M, Colletta G, Romeo MA, Ximenes B, Romano A, Palumbo GA, Di Raimondo F.

J Clin Apher. 2016 Oct;31(5):443-7. doi: 10.1002/jca.21434. Epub 2015 Sep 28.

PMID:
26411360
11.

Added value of multi-pathogen probe-based real-time PCR SeptiFast in the rapid diagnosis of bloodstream infections in patients with bacteraemia.

Mongelli G, Romeo MA, Denaro C, Gennaro M, Fraggetta F, Stefani S.

J Med Microbiol. 2015 Jul;64(7):670-5. doi: 10.1099/jmm.0.000074. Epub 2015 Apr 29.

PMID:
25926679
12.

Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.

Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, Santangelo C, Castiglione G, Giaquinta L, Romeo MA, Vrioni G, Tsakris A.

J Hosp Infect. 2014 Apr;86(4):260-6. doi: 10.1016/j.jhin.2014.02.001. Epub 2014 Feb 20.

PMID:
24680473
13.

Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy.

Pepe A, Meloni A, Rossi G, Cuccia L, D'Ascola GD, Santodirocco M, Cianciulli P, Caruso V, Romeo MA, Filosa A, Pitrolo L, Putti MC, Peluso A, Campisi S, Missere M, Midiri M, Gulino L, Positano V, Lombardi M, Ricchi P.

J Cardiovasc Magn Reson. 2013 Jan 16;15:1. doi: 10.1186/1532-429X-15-1.

14.

Left ventricular rotational dynamics in Beta thalassemia major: a speckle-tracking echocardiographic study.

Monte I, Buccheri S, Bottari V, Blundo A, Licciardi S, Romeo MA.

J Am Soc Echocardiogr. 2012 Oct;25(10):1083-90. doi: 10.1016/j.echo.2012.07.007. Epub 2012 Aug 14.

PMID:
22898242
15.

Feasibility, reproducibility, and reliability for the T*2 iron evaluation at 3 T in comparison with 1.5 T.

Meloni A, Positano V, Keilberg P, De Marchi D, Pepe P, Zuccarelli A, Campisi S, Romeo MA, Casini T, Bitti PP, Gerardi C, Lai ME, Piraino B, Giuffrida G, Secchi G, Midiri M, Lombardi M, Pepe A.

Magn Reson Med. 2012 Aug;68(2):543-51. doi: 10.1002/mrm.23236. Epub 2011 Nov 29.

16.

Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy.

Agodi A, Voulgari E, Barchitta M, Politi L, Koumaki V, Spanakis N, Giaquinta L, Valenti G, Romeo MA, Tsakris A.

J Clin Microbiol. 2011 Nov;49(11):3986-9. doi: 10.1128/JCM.01242-11. Epub 2011 Sep 7.

17.

Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.

Pantalone GR, Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C.

Hemoglobin. 2011;35(3):206-16. doi: 10.3109/03630269.2011.570674.

PMID:
21599433
18.

Prognostic value of CD34+ peak in peripheral blood during mobilization in intermediate-risk AML patients treated in first CR by autologous or allogeneic transplantation.

Milone G, Poidomani M, Leotta S, Avola G, Camuglia MG, Privitera A, Consoli C, Mercurio S, Romeo MA, Di Marco A, Di Mercurio S, Spadaro A, Palumbo GA, Tedeschi P.

Bone Marrow Transplant. 2012 Jan;47(1):24-32. doi: 10.1038/bmt.2011.33. Epub 2011 Mar 14.

PMID:
21399670
19.

Cross-transmission of Klebsiella pneumoniae in two intensive care units: intra- and inter-hospital spread.

Agodi A, Barchitta M, Valenti G, Romeo MA, Giaquinta L, Santangelo C, Castiglione G, Tsakris A.

J Hosp Infect. 2011 Mar;77(3):279-80. doi: 10.1016/j.jhin.2010.10.007. Epub 2011 Jan 28. No abstract available.

PMID:
21277048
20.

Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.

Pepe A, Meloni A, Capra M, Cianciulli P, Prossomariti L, Malaventura C, Putti MC, Lippi A, Romeo MA, Bisconte MG, Filosa A, Caruso V, Quarta A, Pitrolo L, Missere M, Midiri M, Rossi G, Positano V, Lombardi M, Maggio A.

Haematologica. 2011 Jan;96(1):41-7. doi: 10.3324/haematol.2009.019042. Epub 2010 Sep 30.

21.

Genotype-phenotype relationship of the δ-thalassemia and Hb A(2) variants: observation of 52 genotypes.

Lacerra G, Scarano C, Lagona LF, Testa R, Caruso DG, Medulla E, Friscia MG, Mastrullo L, Caldora M, Prezioso R, Gaudiano C, Magnano C, Romeo MA, Musollino G, Di Noce F, Carestia C.

Hemoglobin. 2010;34(5):407-23. doi: 10.3109/03630269.2010.511586.

PMID:
20854114
22.

Emotional impact in beta-thalassaemia major children following cognitive-behavioural family therapy and quality of life of caregiving mothers.

Mazzone L, Battaglia L, Andreozzi F, Romeo MA, Mazzone D.

Clin Pract Epidemiol Ment Health. 2009 Feb 23;5:5. doi: 10.1186/1745-0179-5-5.

23.

Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial.

Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C.

Br J Haematol. 2009 Apr;145(2):245-54. doi: 10.1111/j.1365-2141.2009.07609.x. Epub 2009 Feb 19.

PMID:
19236376
24.

Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.

Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Magnano C, Rizzo M, Caruso V, Gerardi C, Argento C, Campisi S, Cantella F, Commendatore F, D'Ascola DG, Fidone C, Ciancio A, Galati MC, Giuffrida G, Cingari R, Giugno G, Lombardo T, Prossomariti L, Malizia R, Meo A, Roccamo G, Romeo MA, Violi P, Cianciulli P, Rigano P.

Blood Cells Mol Dis. 2009 May-Jun;42(3):247-51. doi: 10.1016/j.bcmd.2009.01.002. Epub 2009 Feb 23.

PMID:
19233692
25.

Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patients.

Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C, Pennisi C, Agodi A.

Int J Hyg Environ Health. 2009 May;212(3):330-7. doi: 10.1016/j.ijheh.2008.07.001. Epub 2008 Sep 3.

PMID:
18771951
26.

Molecular evidences of single mutational events followed by recurrent crossing-overs in the common delta-globin alleles in the Mediterranean area.

Lacerra G, Musollino G, Scarano C, Lagona LF, Caruso DG, Testa R, Prezioso R, Di Noce F, Medulla E, Friscia MG, Mastrullo L, Caldora M, Nota L, Gaudiano C, Magnano C, Ciaccio C, Romeo MA, Carestia C.

Gene. 2008 Feb 29;410(1):129-38. doi: 10.1016/j.gene.2007.12.004. Epub 2007 Dec 14.

PMID:
18221842
27.

Interferon-alpha therapy in Sicilian and Sardinian polytransfused thalassaemic patients with chronic hepatitis C.

Pizzarelli G, Di Gregorio F, Romeo MA, Carboni F, Gallisai D, Solinas A, Malaguarnera M, Musumeci S.

BioDrugs. 1999 Jul;12(1):55-63.

PMID:
18031162
28.

Pseudomonas aeruginosa carriage, colonization, and infection in ICU patients.

Agodi A, Barchitta M, Cipresso R, Giaquinta L, Romeo MA, Denaro C.

Intensive Care Med. 2007 Jul;33(7):1155-1161. doi: 10.1007/s00134-007-0671-6. Epub 2007 May 15.

PMID:
17503016
29.

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Piga A, Romeo MA, Zhao H, Cnaan A.

Blood. 2006 May 1;107(9):3733-7. Epub 2005 Dec 22.

30.

Survival and complications in thalassemia.

Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Origa R, Piga A, Romeo MA, Zhao H, Cnaan A.

Ann N Y Acad Sci. 2005;1054:40-7. Review.

PMID:
16339650
31.

Visceral manifestations of Klippel-Trénaunay syndrome.

Cha SH, Romeo MA, Neutze JA.

Radiographics. 2005 Nov-Dec;25(6):1694-7. No abstract available.

PMID:
16284144
32.

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A.

Haematologica. 2004 Oct;89(10):1187-93.

33.

Acute renal failure following deferoxamine overdose.

Li Volti S, Maccarone C, Li Volti G, Romeo MA.

Pediatr Nephrol. 2003 Oct;18(10):1078-9. Epub 2003 Aug 14. No abstract available.

PMID:
12920634
34.

Antibodies against ox-LDL serum levels in patients with hepatocellular carcinoma.

Motta M, Pistone G, Franzone AM, Romeo MA, Di Mauro S, Giugno I, Ruello P, Malaguarnera M.

Panminerva Med. 2003 Mar;45(1):69-73.

PMID:
12682623
35.

Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units: a 2-year comparison.

Nicoletti G, Bonfiglio G, Bartoloni A, Mattina R, Nicoletti P, Pecile P, Rescaldani R, Romeo MA, Russo G, Savarino O, Stefani S, Paradisi F.

Int J Antimicrob Agents. 2000 Aug;15(4):265-9.

PMID:
10929875
36.

Plasma chitotriosidase activity in patients with beta-thalassemia.

Barone R, Di Gregorio F, Romeo MA, Schilirò G, Pavone L.

Blood Cells Mol Dis. 1999 Feb;25(1):1-8.

PMID:
10349508
37.

Focal neurological deficits in children with beta-thalassemia major.

Incorpora G, Di Gregorio F, Romeo MA, Pavone P, Trifiletti RR, Parano E.

Neuropediatrics. 1999 Feb;30(1):45-8. Review.

PMID:
10222462
38.

Survey of sickle cell disease in Italy.

Russo-Mancuso G, Romeo MA, Guardabasso V, Schilirò G.

Haematologica. 1998 Oct;83(10):875-81.

39.

Thromboembolic events in beta thalassemia major: an Italian multicenter study.

Borgna Pignatti C, Carnelli V, Caruso V, Dore F, De Mattia D, Di Palma A, Di Gregorio F, Romeo MA, Longhi R, Mangiagli A, Melevendi C, Pizzarelli G, Musumeci S.

Acta Haematol. 1998;99(2):76-9.

PMID:
9554453
40.

Clinical and biochemical reactivation of HBV infection in a thalassemic patient after bone marrow transplantation.

Li Volti S, Pizzarelli G, Galimberti M, Di Gregorio F, Romeo MA, Lucarelli G, Russo G.

Infection. 1998 Jan-Feb;26(1):58-60.

PMID:
9505184
41.

Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia.

Giardini C, Galimberti M, Lucarelli G, Polchi P, Angelucci E, Baronciani D, Erer B, Gaziev D, Piga A, Di Gregorio F, Romeo MA, Mangiagli A, Petrelli E, Muretto P.

Bone Marrow Transplant. 1997 Nov;20(9):767-72.

42.

Persistence of Mediterranean anaemia in Sicily.

Romeo MA, Di Gregorio F, Russo G.

J Med Genet. 1997 Oct;34(10):869-70.

43.

An alternative to continuous subcutaneous infusion of desferrioxamine in thalassaemic patients.

Di Gregorio F, Romeo MA, Pizzarelli G, Aiello G, Russo G.

Br J Haematol. 1997 Sep;98(3):601-2.

PMID:
9332314
44.

Evaluation of Taxol cytotoxicity on B-CLL cells in vitro.

Di Raimondo F, Palumbo GA, Romeo MA, Galvagno F, Stagno F, Morabito F, Giustolisi R.

Leuk Lymphoma. 1997 Jun;26(1-2):115-9.

PMID:
9250795
45.

Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus.

Malaguarnera M, Di Fazio I, Romeo MA, Restuccia S, Laurino A, Trovato BA.

J Gastroenterol. 1997 Apr;32(2):211-5.

PMID:
9085170
46.

Interferon enhanced minimal residual disease detection in acute promyelocytic leukaemia.

Palumbo GA, Romeo MA, Di Raimondo F, Giustolisi R.

Br J Haematol. 1997 Mar;96(4):876-7. No abstract available.

PMID:
9074438
47.

Immune status and the immune response to hepatitis B virus vaccine in thalassemic patients after allogeneic bone marrow transplantation.

Li Volti S, Di Gregorio F, Romeo MA, Cannella A, Pizzarelli G, Sciacca A, Russo G.

Bone Marrow Transplant. 1997 Jan;19(2):157-60.

48.

Interleukin-6 in hepatitis C cirrhosis.

Malaguarnera M, Trovato BA, Laurino A, Di Fazio I, Romeo MA, Motta M.

Panminerva Med. 1996 Dec;38(4):207-10.

PMID:
9063027
49.

[Role of interleukin 6 in hepatocellular carcinoma].

Malaguarnera M, Di Fazio I, Laurino A, Romeo MA, Giugno I, Trovato BA.

Bull Cancer. 1996 May;83(5):379-84. French.

PMID:
8680090
50.

Desensitization treatment for anaphylactoid reactions to desferrioxamine in a pediatric patient with thalassemia.

La Rosa M, Romeo MA, Di Gregorio F, Russo G.

J Allergy Clin Immunol. 1996 Jan;97(1 Pt 1):127-8. No abstract available.

PMID:
8568125

Supplemental Content

Loading ...
Support Center